Reply to: "Non selective beta blockers in cirrhosis"

Affiliations

¹ Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria; Vienna Hepatic Hemodynamic Lab, Medical University of Vienna, Vienna, Austria.
² Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria; Vienna Hepatic Hemodynamic Lab, Medical University of Vienna, Vienna, Austria. Electronic address: thomas.reiberger@meduniwien.ac.at.

Comment

Mattias Mandorfer et al. J Hepatol. 2017 Dec.

. 2017 Dec;67(6):1343-1344.

doi: 10.1016/j.jhep.2017.07.018. Epub 2017 Aug 5.

¹ Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria; Vienna Hepatic Hemodynamic Lab, Medical University of Vienna, Vienna, Austria.
² Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria; Vienna Hepatic Hemodynamic Lab, Medical University of Vienna, Vienna, Austria. Electronic address: thomas.reiberger@meduniwien.ac.at.

No abstract available

Comment on

Beta adrenergic blockade and decompensated cirrhosis.
Reiberger T, Mandorfer M. Reiberger T, et al. J Hepatol. 2017 Apr;66(4):849-859. doi: 10.1016/j.jhep.2016.11.001. Epub 2016 Nov 15. J Hepatol. 2017. PMID: 27864004 Review.
Non selective beta blockers in cirrhosis.
Thalheimer U, Giannelli V, Francoz C, Maimone S. Thalheimer U, et al. J Hepatol. 2017 Dec;67(6):1342-1343. doi: 10.1016/j.jhep.2017.05.031. Epub 2017 Aug 5. J Hepatol. 2017. PMID: 28789879 No abstract available.